Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Acetylcholinesterase hydrolyzes the neurotransmitter, acetylcholine at neuromuscular junctions and brain cholinergic synapses, and thus terminates signal transmission. Additionally we are shipping Acetylcholinesterase Kits (55) and Acetylcholinesterase Proteins (19) and many more products for this protein.
Showing 10 out of 273 products:
Human Monoclonal Acetylcholinesterase Primary Antibody for WB - ABIN394128
Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study. in Diabetes Care 2010
Show all 5 references for ABIN394128
Human Monoclonal Acetylcholinesterase Primary Antibody for WB - ABIN1882203
Soreq, Ben-Aziz, Prody, Seidman, Gnatt, Neville, Lieman-Hurwitz, Lev-Lehman, Ginzberg, Lipidot-Lifson: Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure. in Proceedings of the National Academy of Sciences of the United States of America 1991
Show all 3 references for ABIN1882203
Hamster Monoclonal Acetylcholinesterase Primary Antibody for WB - ABIN1882202
Ohno, Brengman, Tsujino, Engel: Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme. in Proceedings of the National Academy of Sciences of the United States of America 1998
Show all 3 references for ABIN1882202
Human Monoclonal Acetylcholinesterase Primary Antibody for IHC (fro), IP - ABIN319453
Fambrough, Engel, Rosenberry: Acetylcholinesterase of human erythrocytes and neuromuscular junctions: homologies revealed by monoclonal antibodies. in Proceedings of the National Academy of Sciences of the United States of America 1982
Show all 2 references for ABIN319453
Human Polyclonal Acetylcholinesterase Primary Antibody for IF, IHC - ABIN2786887
Feldman, Joormann, Johnson: Responses to Positive Affect: A Self-Report Measure of Rumination and Dampening. in Cognitive therapy and research 2010
Show all 2 references for ABIN2786887
Human Polyclonal Acetylcholinesterase Primary Antibody for IF (p), IHC (p) - ABIN741330
Shao, Yu, Zhou, Li, Yang, Pei: Inhibition of miR-134 Protects Against Hydrogen Peroxide-Induced Apoptosis in Retinal Ganglion Cells. in Journal of molecular neuroscience : MN 2015
Human Polyclonal Acetylcholinesterase Primary Antibody for ELISA, WB - ABIN185357
Cottingham, Voskuil, Vaux et al.: The intact human acetylcholinesterase C-terminal oligomerization domain is alpha-helical in situ and in isolation, but a shorter fragment forms beta-sheet-rich amyloid fibrils and protofibrillar ... in Biochemistry 2003
Human Polyclonal Acetylcholinesterase Primary Antibody for EIA, IHC (p) - ABIN360209
Liang, Blouet, Borrega, Bon, Massoulié: Respective roles of the catalytic domains and C-terminal tail peptides in the oligomerization and secretory trafficking of human acetylcholinesterase and butyrylcholinesterase. in The FEBS journal 2008
Data suggest membranes of erythrocytes of patients with chronic obstructive pulmonary disease exhibit the following changes: increase in acetylcholinesterase; decrease in total ATPases and Na+/K+-ATPases; increase in lipid peroxidation/oxidative stress.
toxicogenetics/genetic association study in population in Turkey: Data suggest SNP in PON1 (show PON1 Antibodies) (192Q/R) is associated with susceptibility to organophosphate poisoning; plasma ACHE activities of exposed workers vary w/ PON1 (show PON1 Antibodies) genotype: 192RR>192QR>192QQ.
Data suggest cholinesterase (show BCHE Antibodies) inhibitors with high potency have proper conformation in active site of ACHE and interact with key residues (Trp84, Phe330 at catalytic anionic site; Trp279 at peripheral anionic site; Gly118, Gly119, Ala201 at oxyanion hole.
Phosphorylated p38 (show CRK Antibodies), DNMT1 (show DNMT1 Antibodies) and AChE were aberrantly expressed in a subset of hepatocellular carcinoma tumors.
Report acetylcholinesterase kinetics using fluorogenic probe for the investigation of free thiols.
Report reactivation kinetics of a large series of bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase.
Case Report: repetitive obidoxime treatment induced increase of red blood cell acetylcholinesterase activity even in a late phase of a severe methamidophos poisoning.
Data show that the 3D-quantitative structure property relationship (QSAR) models are capable of explaining the experimental phenomenon of ligand recognition and binding to acetylcholinesterase (AChE).
PRX (show PRDX6 Antibodies)-105 is a plant-derived recombinant version of the human 'read-through' acetylcholinesterase splice variant (AChE-R) which may be used for treatment/prevention of organophosphate poisoning.
Data suggest that natural antisense RNA may play an important role in acetylcholinesterase (AChE) regulation via affecting the epigenetic modification in the AChE promoter region.
To date, AChE and BChE (show BCHE Antibodies) are the only proteins known that include polyproline tetramer organizing peptides in their tetrameric structure.
findings show that AChE induces a remarkable aggregation of PrP (show PRNP Antibodies) 106-126 with a mechanism similar to that described for amyloid beta protein
In this work, the catalytic activity of acetylcholinesterase (AChE) immobilized on these materials was investigated, using neostigmina as AChE inhibitor.
Results strongly support the role of acetylcholinesterase in triggering amyloidogenesis and the potential therapeutic relevance of peripheral site blocker compounds.
Hydrolysis of acetylthiocoline, o-nitroacetanilide and o-nitrotrifluoroacetanilide by fetal bovine serum acetylcholinesterase
iNOS (show NOS2 Antibodies) and AChE expression increases in spiral ganglia treated with streptomycin. Salvia miltiorrhiza injection reduces ototoxicity by reducing the levels of iNOS (show NOS2 Antibodies) and AChE.
In P2Y1R (-/-) mice, acetylcholinesterase expression in muscle was markedly decreased. The proline-rich membrane anchor subunit was reduced by 60 %; while the collagen tail subunit was reduced by 50 %. AChE molecular forms in the muscle were not changed.
Reduction of AChE levels in prion (show PRNP Antibodies)-infected heterozygous AChE knock-out mice leads to slightly but significantly prolonged incubation time.
mRNA expressions of brain specific (show CALY Antibodies) fatty acid protein 7 (fabp-7 (show FABP7 Antibodies)) and phospholipase A2 (show YWHAZ Antibodies) group IV (pla2g4 (show PLA2G4A Antibodies)) were significantly downregulated in AChE-deficient mice.
AChE is regulated in two neuronal cell lines by APP (show APP Antibodies) in a manner independent of the generation of sAPPalpha, sAPPbeta, and AICD.
Deficiency or inhibition of acetylcholinesterase can decrease apoptosis and protect dopaminergic neurons in the neurotoxin model of Parkinson's disease.
Attribute stress-inducible cognitive impairments to cholinergic-mediated induction of miR (show MLXIP Antibodies)-132 and consequently suppressed synaptic ACHE.
assayed the relative activities of AChE and BChE (show BCHE Antibodies) in membrane fractions and culture medium of three different neuronal cell lines, namely the neuroblastoma (show ARHGEF16 Antibodies) cell lines SH-SY5Y and NB7 and the basal forebrain cell line SN56
Long-lasting stress-inducible changes in AChE's promoter choices, identify the chromatin changes that support this long-term transcriptional memory, and reveal HDAC4 (show HDAC5 Antibodies) as a mediator of these effects in the hippocampus.
binding of AChE to laminin-1 (show LAMA1 Antibodies) alters AChE activity and leads to increased neurite growth in culture. A possible mechanism of the AChE effect on neurite outgrowth is proposed due to the interaction of AChE with laminin-1 (show LAMA1 Antibodies).
The reduction of muscle end-plate AChE activity early during the onset of STZ-induced hyperglycemia may contribute to endplate pathology and subsequent muscle weakness during diabetes.
Findings provide evidence that brain acetylcholinesterase (AChE) is a potential target for microcystins (MCs (show MOCOS Antibodies)).
aryl acylamidase associated with acetylcholinesterase was higher than the esterase (show ESD Antibodies) activity on zebrafishembryo
Acetylcholinesterase hydrolyzes the neurotransmitter, acetylcholine at neuromuscular junctions and brain cholinergic synapses, and thus terminates signal transmission. It is also found on the red blood cell membranes, where it constitutes the Yt blood group antigen. Acetylcholinesterase exists in multiple molecular forms which possess similar catalytic properties, but differ in their oligomeric assembly and mode of cell attachment to the cell surface. It is encoded by the single ACHE gene, and the structural diversity in the gene products arises from alternative mRNA splicing, and post-translational associations of catalytic and structural subunits. The major form of acetylcholinesterase found in brain, muscle and other tissues is the hydrophilic species, which forms disulfide-linked oligomers with collagenous, or lipid-containing structural subunits. The other, alternatively spliced form, expressed primarily in the erythroid tissues, differs at the C-terminal end, and contains a cleavable hydrophobic peptide with a GPI-anchor site. It associates with the membranes through the phosphoinositide (PI) moieties added post-translationally.
acetylcholinesterase (Yt blood group)
, acetylcholinesterase isoform E4-E6
, acetylcholine esterase
, Yt blood group
, apoptosis-related acetylcholinesterase
, glycolipid-anchored form of acetylcholinesterase